Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in J Infect

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    May 2018
  1. PT P, B M, Fgj C
    BCG vaccination protects against infection with Mycobacterium tuberculosis ascertained by tuberculin skin testing.
    J Infect. 2018 May 17. pii: S0163-4453(18)30127.
    PubMed     Text format     Abstract available


  2. HOFMANS D, Khodaparast L, Khodaparast L, Vanstreels E, et al
    Ses proteins as possible targets for vaccine development against Staphylococcus epidermidis infections.
    J Infect. 2018 May 9. pii: S0163-4453(18)30130.
    PubMed     Text format     Abstract available


  3. LAO TT, Sahota DS, Chan PKS
    Three Decades of Neonatal Vaccination Has Greatly Reduced Antenatal Prevalence of Hepatitis B Virus Infection Among Gravidae Covered by the Program().
    J Infect. 2018 May 6. pii: S0163-4453(18)30106.
    PubMed     Text format     Abstract available


    January 2018
  4. FABBRINI M, Rigat F, Tuscano G, Chiarot E, et al
    Functional activity of maternal and cord antibodies elicited by an investigational Group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
    J Infect. 2018 Jan 25. pii: S0163-4453(18)30026.
    PubMed     Text format     Abstract available


    December 2017
  5. MARTINON-TORRES F, Carmona Martinez A, Simko R, Infante Marquez P, et al
    Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial.
    J Infect. 2017 Dec 15. pii: S0163-4453(17)30402.
    PubMed     Text format     Abstract available


  6. KAMBIRE D, Soeters HM, Ouedraogo-Traore R, Medah I, et al
    Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015.
    J Infect. 2017 Dec 15. pii: S0163-4453(17)30386.
    PubMed     Text format     Abstract available


    October 2017
  7. BAKER JM, Alonso WJ
    Rotavirus vaccination takes seasonal signature of childhood diarrhea back to pre-sanitation era in Brazil.
    J Infect. 2017 Oct 12. pii: S0163-4453(17)30314.
    PubMed     Text format     Abstract available


  8. ABAD R, Medina V, Farinas MDC, Martinez-Martinez L, et al
    Potential impact of the 4CMenB vaccine on oropharyngeal carriage of neisseria meningitidis.
    J Infect. 2017 Oct 5. pii: S0163-4453(17)30313.
    PubMed     Text format     Abstract available


    September 2017
  9. RONDY M, El Omeiri N, Thompson MG, Leveque A, et al
    Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.
    J Infect. 2017 Sep 18. pii: S0163-4453(17)30299.
    PubMed     Text format     Abstract available


    August 2017
  10. TANG JW, Mutuyimana J, Teo KW, Lea S, et al
    Early seasonal influenza vaccination and delayed influenza peaks - a possible cause of end-of-season outbreaks.
    J Infect. 2017 Aug 10. pii: S0163-4453(17)30259.
    PubMed     Text format     Abstract available


  11. LUCIDARME J, Lekshmi A, Parikh SR, Bray JE, et al
    Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?
    J Infect. 2017;75:95-103.
    PubMed     Text format     Abstract available


    July 2017
  12. BORROW R, Caugant DA, Ceyhan M, Christensen H, et al
    Meningococcal disease in the Middle East and Africa: Findings and updates from the Global Meningococcal Initiative.
    J Infect. 2017;75:1-11.
    PubMed     Text format     Abstract available


  13. SUDENGA SL, Nyitray AG, Torres BN, Silva R, et al
    Comparison of anal HPV natural history among men by country of residence: Brazil, Mexico, and the United States.
    J Infect. 2017;75:35-47.
    PubMed     Text format     Abstract available


    June 2017
  14. RODRIGUES CMC, Pinto MV, Sadarangani M, Plotkin SA, et al
    Whither vaccines?
    J Infect. 2017;74 Suppl 1:S2-S9.
    PubMed     Text format     Abstract available


  15. LUBY SP
    Clean water, clean hands or new vaccines?
    J Infect. 2017;74 Suppl 1:S18-S22.
    PubMed     Text format     Abstract available


  16. GERRETSEN HE, Sande CJ
    Development of respiratory syncytial virus (RSV) vaccines for infants.
    J Infect. 2017;74 Suppl 1:S143-S146.
    PubMed     Text format     Abstract available


  17. MINA MJ
    Generalized herd effects and vaccine evaluation: impact of live influenza vaccine on off-target bacterial colonisation.
    J Infect. 2017;74 Suppl 1:S101-S107.
    PubMed     Text format     Abstract available


  18. MINA MJ
    Measles, immune suppression and vaccination: direct and indirect nonspecific vaccine benefits.
    J Infect. 2017;74 Suppl 1:S10-S17.
    PubMed     Text format     Abstract available


  19. GERSHON AA
    Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?
    J Infect. 2017;74 Suppl 1:S27-S33.
    PubMed     Text format     Abstract available


  20. PINTO MV, Merkel TJ
    Pertussis disease and transmission and host responses: insights from the baboon model of pertussis.
    J Infect. 2017;74 Suppl 1:S114-S119.
    PubMed     Text format     Abstract available


  21. PARENT DU CHATELET I, Deghmane AE, Antona D, Hong E, et al
    Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.
    J Infect. 2017;74:564-574.
    PubMed     Text format     Abstract available


    May 2017
  22. HARDER T, Koch J, Wichmann O, Hellenbrand W, et al
    Predicted vs observed effectiveness of outer membrane vesicle (OMV) vaccines against meningococcal serogroup B disease: systematic review.
    J Infect. 2017 May 6. pii: S0163-4453(17)30135.
    PubMed     Text format     Abstract available


    March 2017
  23. MAZZOLA G, Macaluso FS, Adamoli L, Renna S, et al
    Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.
    J Infect. 2017 Mar 2. pii: S0163-4453(17)30075.
    PubMed     Text format     Abstract available


    January 2017
  24. WOESTENBERG PJ, King AJ, van der Sande MA, Donken R, et al
    No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    J Infect. 2017 Jan 23. pii: S0163-4453(17)30026.
    PubMed     Text format     Abstract available


    December 2016
  25. AHMED A, Sahota A, Stephenson I, Brown KE, et al
    Measles - a tale of two sisters, vaccine failure, and the resurgence of an old foe.
    J Infect. 2016 Dec 30. pii: S0163-4453(16)30343.
    PubMed     Text format    


    August 2016
  26. MARSHALL H, Nissen M, Richmond P, Shakib S, et al
    Safety and Immunogenicity of a Booster Dose of a 3-antigen Staphylococcus aureus Vaccine (SA3Ag) in Healthy Adults: A Randomized Phase 1 Study.
    J Infect. 2016 Aug 9. pii: S0163-4453(16)30208.
    PubMed     Text format     Abstract available


    July 2016
  27. SANTHI D, Raja A
    T cell recall response of two hypothetical proteins (Rv2251 and Rv2721c) from Mycobacterium tuberculosis in healthy household contacts of TB - possible subunit vaccine candidates.
    J Infect. 2016 Jul 9. pii: S0163-4453(16)30159.
    PubMed     Text format     Abstract available


    May 2016
  28. STANLEY M
    Preventing cervical cancer and genital warts - How much protection is enough for HPV vaccines?
    J Infect. 2016 May 19. pii: S0163-4453(16)30045.
    PubMed     Text format     Abstract available


  29. LAO TT, Chung MK, Cheung TK, Law LW, et al
    Antenatal hepatitis B and increased risk of gestational diabetes mellitus--Implications for obstetric care.
    J Infect. 2016;72:625-6.
    PubMed     Text format    


    April 2016
  30. CURRAN T, Coyle PV
    Understanding the true burden and infection dynamics of Bordetella pertussis using molecular diagnostics.
    J Infect. 2016;72:504-5.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: